Webcast of Investor Briefing: ASCO GU ZIRCON Phase III Results Presentation

21 February 2023

Telix is pleased to provide a webcast recording of A/Prof Brian Shuch and Dr Colin Hayward, Telix Group Chief Medical Officer delivering an investor briefing on the ZIRCON Phase III Results recently presented at ASCO GU. The briefing provided an opportunity for investors to hear Dr Shuch’s ASCO GU presentation and a clinician’s perspective on the clinical utility of this investigational imaging agent.

To view the webcast please click here.